chief executive officer (CEO) and representative director, when Mr. Weber retires from the company in June 2026. Mrs. Kim will be proposed as a candidate for election to the Board at Takeda’s ...

As Korean beauty brands gain global popularity, combined with innovation and affordability, foreign entrepreneurs and startup ...

Match Group Inc. named Zillow Group Inc. co-founder Spencer Rascoff as its new chief executive officer, replacing Bernard Kim ...

Former figure skating national team member Kim Yuna has expressed her condolences for the members of a figure skating team ...

President Donald Trump met Friday with Nvidia CEO Jensen Huang, marking the first meeting between the president and the leader of a chip company at the center of the artificial intelligence gold ...

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...

Takeda Pharmaceutical raised its annual earnings forecasts despite posting lower quarterly net profit, and it said Julie Kim, who heads its U.S. business unit, will become chief executive in 2026.

CEO and representative director, when Weber retires from the company in June 2026. Kim will be proposed as a candidate for election to the board at Takeda’s annual general shareholders meeting ...

The drugmaker said Thursday that Kim, president of its U.S. business unit, will succeed CEO Christophe Weber, who plans to step down in June next year. The U.S. is by far the largest market for ...